2026. Bimekizumab Long-Term On-Treatment Remission and Associated Sustained Improvements in Quality of Life in Moderate to Severe Plaque Psoriasis Across Five Phase 3/3b Trials. SKIN The Journal of Cutaneous Medicine. 10, 3 (May 2026), s772. DOI:https://doi.org/10.25251/pkdcct35.